Gilla Kaplan

30.2k total citations · 9 hit papers
267 papers, 23.9k citations indexed

About

Gilla Kaplan is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Gilla Kaplan has authored 267 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Infectious Diseases, 130 papers in Epidemiology and 93 papers in Immunology. Recurrent topics in Gilla Kaplan's work include Tuberculosis Research and Epidemiology (116 papers), Mycobacterium research and diagnosis (104 papers) and Leprosy Research and Treatment (58 papers). Gilla Kaplan is often cited by papers focused on Tuberculosis Research and Epidemiology (116 papers), Mycobacterium research and diagnosis (104 papers) and Leprosy Research and Treatment (58 papers). Gilla Kaplan collaborates with scholars based in United States, South Africa and Norway. Gilla Kaplan's co-authors include Zanvil A. Cohn, André L. Moreira, Laura G. Corral, Patrick Haslett, Liana Tsenova, E P Sampaio, Clifton E. Barry, Claudia Manca, Euzenir Nunes Sarno and Victoria H. Freedman and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gilla Kaplan

265 papers receiving 23.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

1991 997 citations E P Sampaio, Euzenir Nunes Sarno et al. The Journal of Experimental Medicine profile →
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

1993 890 citations André L. Moreira, E P Sampaio et al. The Journal of Experimental Medicine profile →
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

1999 635 citations Laura G. Corral, Patrick Haslett et al. profile →
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

2004 580 citations Claudia Manca, Amy K. Barczak et al. profile →
Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α

1999 577 citations Laura G. Corral, Patrick Haslett et al. The Journal of Immunology profile →
Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro.

1979 418 citations Gilla Kaplan et al. The Journal of Experimental Medicine profile →
Metformin as adjunct antituberculosis therapy

2014 378 citations Liana Tsenova, Barry N. Kreiswirth et al. profile →
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy

1986 261 citations Gilla Kaplan, C. K. Job et al. profile →
The Cutaneous Infiltrates of Leprosy

1982 178 citations Gilla Kaplan, Euzenir Nunes Sarno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilla Kaplan United States	82	10.8k	8.8k	7.8k	5.7k	4.2k	267	23.9k
Stephan R. Targan United States	90	2.3k 0.2×	12.5k 1.4×	11.5k 1.5×	4.4k 0.8×	6.0k 1.4×	434	31.0k
Sander J. H. van Deventer Netherlands	72	1.8k 0.2×	7.7k 0.9×	7.3k 0.9×	4.0k 0.7×	4.9k 1.2×	269	22.1k
Robert L. Modlin United States	113	9.9k 0.9×	10.3k 1.2×	21.5k 2.7×	6.1k 1.1×	3.3k 0.8×	356	38.3k
Klaus Pfeffer Germany	77	3.5k 0.3×	4.7k 0.5×	14.1k 1.8×	9.2k 1.6×	2.5k 0.6×	266	28.3k
Jay K. Kolls United States	101	5.8k 0.5×	8.5k 1.0×	21.6k 2.8×	8.5k 1.5×	3.2k 0.8×	477	40.9k
Robert W. Finberg United States	77	5.1k 0.5×	7.1k 0.8×	9.7k 1.2×	7.2k 1.3×	1.1k 0.3×	260	24.5k
Warren Strober United States	114	3.0k 0.3×	8.0k 0.9×	26.2k 3.3×	11.6k 2.0×	6.6k 1.6×	437	49.5k
Howard A. Young United States	97	3.2k 0.3×	3.4k 0.4×	16.6k 2.1×	9.5k 1.7×	2.5k 0.6×	369	31.4k
Hermann Einsele Germany	86	6.2k 0.6×	8.8k 1.0×	6.0k 0.8×	6.9k 1.2×	975 0.2×	761	29.8k
Tom H. M. Ottenhoff Netherlands	86	13.8k 1.3×	11.2k 1.3×	12.8k 1.6×	5.3k 0.9×	4.1k 1.0×	471	25.8k

Countries citing papers authored by Gilla Kaplan

Since Specialization

Citations

This map shows the geographic impact of Gilla Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilla Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilla Kaplan more than expected).

Fields of papers citing papers by Gilla Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilla Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilla Kaplan. The network helps show where Gilla Kaplan may publish in the future.

Co-authorship network of co-authors of Gilla Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Gilla Kaplan. A scholar is included among the top collaborators of Gilla Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilla Kaplan. Gilla Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kolloli, Afsal, et al.. (2023). A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection. Frontiers in Immunology. 14. 1270414–1270414. 5 indexed citations

Dinkele, Ryan, Ronnett Seldon, Anastasia Koch, et al.. (2021). Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols. PLoS Pathogens. 17(2). e1009262–e1009262. 31 indexed citations

Mahapatra, Sebabrata, Ann M. Hess, John L. Johnson, et al.. (2014). A metabolic biosignature of early response to anti-tuberculosis treatment. BMC Infectious Diseases. 14(1). 53–53. 62 indexed citations

Tsenova, Liana, Paul E. O’Brien, Blas Peixoto, et al.. (2014). Etanercept Exacerbates Inflammation and Pathology in a Rabbit Model of Active Pulmonary Tuberculosis. Journal of Interferon & Cytokine Research. 34(9). 716–726. 17 indexed citations

Manca, Claudia, Blas Peixoto, Wladimir Malaga, Christophe Guilhot, & Gilla Kaplan. (2011). Modulation of the Cytokine Response in Human Monocytes by Mycobacterium leprae Phenolic Glycolipid-1. Journal of Interferon & Cytokine Research. 32(1). 27–33. 19 indexed citations

Day, Cheryl L., Nazma Mansoor, Marwou de Kock, et al.. (2011). HIV-Specific Gag Responses in Early Infancy Correlate with Clinical Outcome and Inversely with Viral Load. AIDS Research and Human Retroviruses. 27(12). 1311–1316. 4 indexed citations

Subbian, Selvakumar, Liana Tsenova, Paul E. O’Brien, et al.. (2011). Phosphodiesterase-4 Inhibition Combined with Isoniazid Treatment of Rabbits with Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology. American Journal Of Pathology. 179(1). 289–301. 68 indexed citations

Kagina, Benjamin M., Bernd Abel, Thomas J. Scriba, et al.. (2010). Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns. American Journal of Respiratory and Critical Care Medicine. 182(8). 1073–1079. 324 indexed citations

Middelkoop, Keren, Linda‐Gail Bekker, Landon Myer, et al.. (2010). Antiretroviral Program Associated with Reduction in Untreated Prevalent Tuberculosis in a South African Township. American Journal of Respiratory and Critical Care Medicine. 182(8). 1080–1085. 50 indexed citations

10.

Wood, Robin, Keren Middelkoop, Landon Myer, et al.. (2006). Undiagnosed Tuberculosis in a Community with High HIV Prevalence. American Journal of Respiratory and Critical Care Medicine. 175(1). 87–93. 196 indexed citations

11.

Freeman, Sherry, Frank A. Post, Linda‐Gail Bekker, et al.. (2006). Mycobacterium tuberculosis H37Ra and H37Rv Differential Growth and Cytokine/Chemokine Induction in Murine Macrophages In Vitro. Journal of Interferon & Cytokine Research. 26(1). 27–33. 37 indexed citations

12.

Tsenova, Liana, et al.. (2006). Aerosol Exposure System for Rabbits: Application to M. Tuberculosis Infection. Applied Biosafety. 11(1). 7–14. 7 indexed citations

13.

Melikoğlu, Melike, James G. Krueger, Gilla Kaplan, et al.. (2006). Characterization of the Divergent Wound-Healing Responses Occurring in the Pathergy Reaction and Normal Healthy Volunteers. The Journal of Immunology. 177(9). 6415–6421. 50 indexed citations

14.

Manca, Claudia, Liana Tsenova, Sherry Freeman, et al.. (2005). Hypervirulent M. tuberculosis W/Beijing Strains Upregulate Type I IFNs and Increase Expression of Negative Regulators of the Jak-Stat Pathway. Journal of Interferon & Cytokine Research. 25(11). 694–701. 240 indexed citations

15.

Kaplan, Gilla, Frank A. Post, André L. Moreira, et al.. (2003). Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity. Infection and Immunity. 71(12). 7099–7108. 277 indexed citations

16.

Kaplan, Gilla, Steve D. Thomas, Daniel S. Fierer, et al.. (2000). Thalidomide for the Treatment of AIDS-Associated Wasting. AIDS Research and Human Retroviruses. 16(14). 1345–1355. 67 indexed citations

17.

Oliver, Stephen J., Sherry Freeman, Laura G. Corral, Christopher Ocampo, & Gilla Kaplan. (1999). Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis. Clinical & Experimental Immunology. 118(2). 315–321. 26 indexed citations

18.

Haslett, Patrick, Victoria H. Freedman, & Gilla Kaplan. (1997). The emerging role of thalidomide therapy in HIV-infected patients. 14(5). 4 indexed citations

19.

Sampaio, E P, André L. Moreira, Euzenir Nunes Sarno, Ananda Malta, & Gilla Kaplan. (1992). Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.. The Journal of Experimental Medicine. 175(6). 1729–1737. 118 indexed citations

20.

Kaplan, Gilla, Rolf Kiessling, Gerald E. Hancock, et al.. (1989). The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.. The Journal of Experimental Medicine. 169(3). 893–907. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact